Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Aplastic Astrocytoma - Overview
Aplastic Astrocytoma - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Aplastic Astrocytoma - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Aplastic Astrocytoma - Companies Involved in Therapeutics Development
A. Merini Industrie Farmaceutiche Riunite Srl
AbbVie Inc
Aettis Inc
AngioChem Inc
Apexigen Inc
Bayer AG
Berg LLC
Boehringer Ingelheim Intertiol GmbH
Bristol-Myers Squibb Co
Calithera Biosciences Inc
Candel Therapeutics Inc
CDG Therapeutics Inc
Cellix Bio Pvt Ltd
Chimerix Inc
Cothera Bioscience Pty Ltd
Curis Inc
Everfront Biotech Inc
Fore Biotherapeutics Inc
Geneos Therapeutics Inc
Ipsen SA
Karyopharm Therapeutics Inc
Kazia Therapeutics Ltd
Merck KGaA
MimiVax LLC
Mustang Bio Inc
scent Biotech Inc
Novartis AG
OncoSynergy Inc
Orbus Therapeutics Inc
Orphelia Pharma SAS
Otsuka Pharmaceutical Co Ltd
Pfizer Inc
PTC Therapeutics Inc
TheraBiologics Inc
Wayshine Biopharma Inc
Wuhan Binhui Biotechnology Co Ltd
Aplastic Astrocytoma - Drug Profiles
afatinib dimaleate - Drug Profile
Product Description
Mechanism Of Action
aglatimagene besadenovec - Drug Profile
Product Description
Mechanism Of Action
BAY-1436032 - Drug Profile
Product Description
Mechanism Of Action
BAY-2666605 - Drug Profile
Product Description
Mechanism Of Action
Cellular Immunotherapy for Oncology - Drug Profile
Product Description
Mechanism Of Action
Cellular Immunotherapy for Oncology - Drug Profile
Product Description
Mechanism Of Action
Cellular Immunotherapy for Oncology - Drug Profile
Product Description
Mechanism Of Action
CLXONC-643 - Drug Profile
Product Description
Mechanism Of Action
dabrafenib mesylate - Drug Profile
Product Description
Mechanism Of Action
eflornithine - Drug Profile
Product Description
Mechanism Of Action
fimepinostat - Drug Profile
Product Description
Mechanism Of Action
FORE-8394 - Drug Profile
Product Description
Mechanism Of Action
futibatinib - Drug Profile
Product Description
Mechanism Of Action
G-207 - Drug Profile
Product Description
Mechanism Of Action
GENPV-001 - Drug Profile
Product Description
Mechanism Of Action
irinotecan hydrochloride - Drug Profile
Product Description
Mechanism Of Action
M-032 - Drug Profile
Product Description
Mechanism Of Action
MB-108 - Drug Profile
Product Description
Mechanism Of Action
MB-110 - Drug Profile
Product Description
Mechanism Of Action
OH-2 - Drug Profile
Product Description
Mechanism Of Action
ON-01 - Drug Profile
Product Description
Mechanism Of Action
ONC-206 - Drug Profile
Product Description
Mechanism Of Action
OS-2966 - Drug Profile
Product Description
Mechanism Of Action
P-28 - Drug Profile
Product Description
Mechanism Of Action
paclitaxel trevatide - Drug Profile
Product Description
Mechanism Of Action
palbociclib - Drug Profile
Product Description
Mechanism Of Action
paxalisib - Drug Profile
Product Description
Mechanism Of Action
pritumumab - Drug Profile
Product Description
Mechanism Of Action
regorafenib - Drug Profile
Product Description
Mechanism Of Action
ribociclib succite - Drug Profile
Product Description
Mechanism Of Action
selinexor - Drug Profile
Product Description
Mechanism Of Action
SL-701 - Drug Profile
Product Description
Mechanism Of Action
sorafenib tosylate - Drug Profile
Product Description
Mechanism Of Action
sotigalimab - Drug Profile
Product Description
Mechanism Of Action
SurVaxM - Drug Profile
Product Description
Mechanism Of Action
TBX.OncV NSC - Drug Profile
Product Description
Mechanism Of Action
telaglestat hydrochloride - Drug Profile
Product Description
Mechanism Of Action
temozolomide - Drug Profile
Product Description
Mechanism Of Action
tepotinib hydrochloride - Drug Profile
Product Description
Mechanism Of Action
trotabresib - Drug Profile
Product Description
Mechanism Of Action
ubidecarenone - Drug Profile
Product Description
Mechanism Of Action
unesbulin - Drug Profile
Product Description
Mechanism Of Action
veliparib ER - Drug Profile
Product Description
Mechanism Of Action
WSD-0922 - Drug Profile
Product Description
Mechanism Of Action
z-90099 - Drug Profile
Product Description
Mechanism Of Action
zotiraciclib citrate - Drug Profile
Product Description
Mechanism Of Action
Aplastic Astrocytoma - Dormant Projects
Aplastic Astrocytoma - Discontinued Products
Aplastic Astrocytoma - Product Development Milestones
Featured News & Press Releases
Jan 19, 2022: Orbus Therapeutics’ phase 3 Eflornithine STELLAR study reaches full patient enrollment
Sep 28, 2021: Orbus Therapeutics granted European patent for method of use for Eflornithine
Mar 02, 2021: Orbus Therapeutics announces positive outcome of pre-planned interim futility alysis for phase 3 Eflornithine STELLAR study
Dec 23, 2020: Orbus Therapeutics receives U.S. Patent for Eflornithine formulations
Jul 10, 2020: Geneos Therapeutics announces first patient dosed with its D-based, neoantigen-targeting persolized vaccine technology
Feb 04, 2020: STELLAR clinical trial of eflornithine to enrol brain tumour patients
May 16, 2019: Adastra Pharmaceuticals announces that data from phase 1b clinical trial of Zotiraciclib will be presented at ASCO 2019
Jun 05, 2017: Orbus Therapeutics Announces ASCO Study Design Presentation of Pivotal Clinical Trial in Patients with Late-Stage Brain Cancer
Sep 26, 2016: Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Anaplastic Astrocytoma, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Anaplastic Astrocytoma, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Anaplastic Astrocytoma - Dormant Projects, 2022
Anaplastic Astrocytoma - Dormant Projects, 2022 (Contd..1)
Anaplastic Astrocytoma - Dormant Projects, 2022 (Contd..2)
Anaplastic Astrocytoma - Discontinued Products, 2022